These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
300 related articles for article (PubMed ID: 26840265)
1. Epithelioid hemangioendotheliomas with TFE3 gene translocations are compossible with CAMTA1 gene rearrangements. Lee SJ; Yang WI; Chung WS; Kim SK Oncotarget; 2016 Feb; 7(7):7480-8. PubMed ID: 26840265 [TBL] [Abstract][Full Text] [Related]
4. Multicentric visceral epithelioid hemangioendothelioma, with extremity dermal deposits, unusual late recurrence on the nasal bridge, and TFE3 gene rearrangement. Thway K; Mentzel T; Perrett CM; Calonje E Hum Pathol; 2018 Feb; 72():153-159. PubMed ID: 28855107 [TBL] [Abstract][Full Text] [Related]
5. CAMTA1 is a useful immunohistochemical marker for diagnosing epithelioid haemangioendothelioma. Shibuya R; Matsuyama A; Shiba E; Harada H; Yabuki K; Hisaoka M Histopathology; 2015 Dec; 67(6):827-35. PubMed ID: 25879300 [TBL] [Abstract][Full Text] [Related]
6. YAP1-TFE3 epithelioid hemangioendothelioma: a case without vasoformation and a new transcript variant. Puls F; Niblett A; Clarke J; Kindblom LG; McCulloch T Virchows Arch; 2015 Apr; 466(4):473-8. PubMed ID: 25680571 [TBL] [Abstract][Full Text] [Related]
7. CAMTA-1 Expression in 24 Cases of Hepatic Epithelioid Hemangioendothelioma in a Single Institute: Diagnostic Utility for Differential Diagnosis from Hepatic Angiosarcoma. Jung H; Kim HN; Jang Y; Park CK; Ha SY In Vivo; 2019; 33(6):2293-2297. PubMed ID: 31662570 [TBL] [Abstract][Full Text] [Related]
8. TFE3-rearranged hepatic epithelioid hemangioendothelioma-a case report with immunohistochemical and molecular study. Kuo FY; Huang HY; Chen CL; Eng HL; Huang CC APMIS; 2017 Sep; 125(9):849-853. PubMed ID: 28585251 [TBL] [Abstract][Full Text] [Related]
9. Prognostic stratification of clinical and molecular epithelioid hemangioendothelioma subsets. Rosenbaum E; Jadeja B; Xu B; Zhang L; Agaram NP; Travis W; Singer S; Tap WD; Antonescu CR Mod Pathol; 2020 Apr; 33(4):591-602. PubMed ID: 31537895 [TBL] [Abstract][Full Text] [Related]
10. Thoracic epithelioid malignant vascular tumors: a clinicopathologic study of 52 cases with emphasis on pathologic grading and molecular studies of WWTR1-CAMTA1 fusions. Anderson T; Zhang L; Hameed M; Rusch V; Travis WD; Antonescu CR Am J Surg Pathol; 2015 Jan; 39(1):132-9. PubMed ID: 25353289 [TBL] [Abstract][Full Text] [Related]
11. Epithelioid hemangioendothelioma (EHE) with WWTR1::TFE3 gene fusion, a novel fusion variant. Li S; Dermawan JK; Seavey CN; Ma S; Antonescu CR; Rubin BP Genes Chromosomes Cancer; 2024 Feb; 63(2):e23226. PubMed ID: 38380774 [TBL] [Abstract][Full Text] [Related]
12. A novel WWTR1-CAMTA1 gene fusion is a consistent abnormality in epithelioid hemangioendothelioma of different anatomic sites. Errani C; Zhang L; Sung YS; Hajdu M; Singer S; Maki RG; Healey JH; Antonescu CR Genes Chromosomes Cancer; 2011 Aug; 50(8):644-53. PubMed ID: 21584898 [TBL] [Abstract][Full Text] [Related]
14. Pleural epithelioid hemangioendothelioma harboring CAMTA1 rearrangement. Ha SY; Choi IH; Han J; Choi YL; Cho JH; Lee KJ; Sun JM Lung Cancer; 2014 Mar; 83(3):411-5. PubMed ID: 24461304 [TBL] [Abstract][Full Text] [Related]
15. PSF/SFPQ is a very common gene fusion partner in TFE3 rearrangement-associated perivascular epithelioid cell tumors (PEComas) and melanotic Xp11 translocation renal cancers: clinicopathologic, immunohistochemical, and molecular characteristics suggesting classification as a distinct entity. Rao Q; Shen Q; Xia QY; Wang ZY; Liu B; Shi SS; Shi QL; Yin HL; Wu B; Ye SB; Li L; Chen JY; Pan MH; Li Q; Li R; Wang X; Zhang RS; Yu B; Ma HH; Lu ZF; Zhou XJ Am J Surg Pathol; 2015 Sep; 39(9):1181-96. PubMed ID: 26274027 [TBL] [Abstract][Full Text] [Related]
16. [Epithelioid hemangioendothelioma with TFE3 translocation in soft tissue:a clinicopathological study]. Song QY; Zhu XM; Song GX; Li X; Fan QH; Zhang ZH; Gong QX Zhonghua Bing Li Xue Za Zhi; 2021 Oct; 50(10):1151-1156. PubMed ID: 34619869 [No Abstract] [Full Text] [Related]
17. Identification of a disease-defining gene fusion in epithelioid hemangioendothelioma. Tanas MR; Sboner A; Oliveira AM; Erickson-Johnson MR; Hespelt J; Hanwright PJ; Flanagan J; Luo Y; Fenwick K; Natrajan R; Mitsopoulos C; Zvelebil M; Hoch BL; Weiss SW; Debiec-Rychter M; Sciot R; West RB; Lazar AJ; Ashworth A; Reis-Filho JS; Lord CJ; Gerstein MB; Rubin MA; Rubin BP Sci Transl Med; 2011 Aug; 3(98):98ra82. PubMed ID: 21885404 [TBL] [Abstract][Full Text] [Related]
18. YAP1-TFE3-fused hemangioendothelioma: a multi-institutional clinicopathologic study of 24 genetically-confirmed cases. Dermawan JK; Azzato EM; Billings SD; Fritchie KJ; Aubert S; Bahrami A; Barisella M; Baumhoer D; Blum V; Bode B; Aesif SW; Bovée JVMG; Dickson BC; van den Hout M; Lucas DR; Moch H; Oaxaca G; Righi A; Sciot R; Sumathi V; Yoshida A; Rubin BP Mod Pathol; 2021 Dec; 34(12):2211-2221. PubMed ID: 34381186 [TBL] [Abstract][Full Text] [Related]
19. Epithelioid Hemangioendothelioma: a Rare Primary Thyroid Tumor with Confirmation of WWTR1 and CAMTA1 Rearrangements. Shah AA; Ohori NP; Yip L; Coyne C; Antonescu CR; Seethala RR Endocr Pathol; 2016 Jun; 27(2):147-52. PubMed ID: 27026033 [TBL] [Abstract][Full Text] [Related]
20. TAZ-CAMTA1 and YAP-TFE3 alter the TAZ/YAP transcriptome by recruiting the ATAC histone acetyltransferase complex. Merritt N; Garcia K; Rajendran D; Lin ZY; Zhang X; Mitchell KA; Borcherding N; Fullenkamp C; Chimenti MS; Gingras AC; Harvey KF; Tanas MR Elife; 2021 Apr; 10():. PubMed ID: 33913810 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]